A citation-based method for searching scientific literature

Divya Pathania, Melissa Millard, Nouri Neamati. Adv Drug Deliv Rev 2009
Times Cited: 172







List of co-cited articles
764 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Targeting mitochondria for cancer therapy.
Simone Fulda, Lorenzo Galluzzi, Guido Kroemer. Nat Rev Drug Discov 2010
19

Understanding the Warburg effect: the metabolic requirements of cell proliferation.
Matthew G Vander Heiden, Lewis C Cantley, Craig B Thompson. Science 2009
16

On the origin of cancer cells.
O WARBURG. Science 1956
16

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
14

Cancer cell metabolism: Warburg and beyond.
Peggy P Hsu, David M Sabatini. Cell 2008
10

Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.
Jacek Zielonka, Joy Joseph, Adam Sikora, Micael Hardy, Olivier Ouari, Jeannette Vasquez-Vivar, Gang Cheng, Marcos Lopez, Balaraman Kalyanaraman. Chem Rev 2017
543
10

Drug delivery to mitochondria: the key to mitochondrial medicine.
M P Murphy, R A Smith. Adv Drug Deliv Rev 2000
316
8

Tumor cell metabolism: cancer's Achilles' heel.
Guido Kroemer, Jacques Pouyssegur. Cancer Cell 2008
8

Targeting cancer cell mitochondria as a therapeutic approach.
Shijun Wen, Daqian Zhu, Peng Huang. Future Med Chem 2013
131
7

Mitochondrially targeted anti-cancer agents.
Lucia Biasutto, Lan-Feng Dong, Mario Zoratti, Jiri Neuzil. Mitochondrion 2010
94
7

Mitochondrial dysfunction in cancer.
Josephine S Modica-Napolitano, Keshav K Singh. Mitochondrion 2004
228
7

Mitochondria as a pharmacological target.
Adam Szewczyk, Lech Wojtczak. Pharmacol Rev 2002
369
7

Targeting mitochondria metabolism for cancer therapy.
Samuel E Weinberg, Navdeep S Chandel. Nat Chem Biol 2015
796
7



Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells.
Min Han, Mohammad Reza Vakili, Hoda Soleymani Abyaneh, Ommoleila Molavi, Raymond Lai, Afsaneh Lavasanifar. Mol Pharm 2014
129
6

Mitochondrial form and function.
Jonathan R Friedman, Jodi Nunnari. Nature 2014
836
6

Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity.
Frank Weinberg, Robert Hamanaka, William W Wheaton, Samuel Weinberg, Joy Joseph, Marcos Lopez, Balaraman Kalyanaraman, Gökhan M Mutlu, G R Scott Budinger, Navdeep S Chandel. Proc Natl Acad Sci U S A 2010
6

Mitochondria in cancer cells: what is so special about them?
Vladimir Gogvadze, Sten Orrenius, Boris Zhivotovsky. Trends Cell Biol 2008
442
6

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham, Jerome Alexandre, Peng Huang. Nat Rev Drug Discov 2009
6

Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis.
William W Wheaton, Samuel E Weinberg, Robert B Hamanaka, Saul Soberanes, Lucas B Sullivan, Elena Anso, Andrea Glasauer, Eric Dufour, Gokhan M Mutlu, Gr Scott Budigner,[...]. Elife 2014
637
6

Cancer drug resistance: an evolving paradigm.
Caitriona Holohan, Sandra Van Schaeybroeck, Daniel B Longley, Patrick G Johnston. Nat Rev Cancer 2013
6

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
6

Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives.
Gantumur Battogtokh, Yeon Su Choi, Dong Seop Kang, Sang Jun Park, Min Suk Shim, Kang Moo Huh, Yong-Yeon Cho, Joo Young Lee, Hye Suk Lee, Han Chang Kang. Acta Pharm Sin B 2018
100
6

Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.
Andrea Viale, Piergiorgio Pettazzoni, Costas A Lyssiotis, Haoqiang Ying, Nora Sánchez, Matteo Marchesini, Alessandro Carugo, Tessa Green, Sahil Seth, Virginia Giuliani,[...]. Nature 2014
732
5

Metabolic modulation of glioblastoma with dichloroacetate.
E D Michelakis, G Sutendra, P Dromparis, L Webster, A Haromy, E Niven, C Maguire, T-L Gammer, J R Mackey, D Fulton,[...]. Sci Transl Med 2010
498
5


Delivery of bioactive molecules to mitochondria in vivo.
Robin A J Smith, Carolyn M Porteous, Alison M Gane, Michael P Murphy. Proc Natl Acad Sci U S A 2003
464
5

Classification of mitocans, anti-cancer drugs acting on mitochondria.
Jiri Neuzil, Lan-Feng Dong, Jakub Rohlena, Jaroslav Truksa, Stephen J Ralph. Mitochondrion 2013
152
5

Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Simran S Sabharwal, Paul T Schumacker. Nat Rev Cancer 2014
846
5

A review of stimuli-responsive nanocarriers for drug and gene delivery.
Srinivas Ganta, Harikrishna Devalapally, Aliasgar Shahiwala, Mansoor Amiji. J Control Release 2008
5

THE METABOLISM OF TUMORS IN THE BODY.
O Warburg, F Wind, E Negelein. J Gen Physiol 1927
5

Mitochondria and apoptosis.
D R Green, J C Reed. Science 1998
5

Akt stimulates aerobic glycolysis in cancer cells.
Rebecca L Elstrom, Daniel E Bauer, Monica Buzzai, Robyn Karnauskas, Marian H Harris, David R Plas, Hongming Zhuang, Ryan M Cinalli, Abass Alavi, Charles M Rudin,[...]. Cancer Res 2004
5


Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.
Krushna C Patra, Qi Wang, Prashanth T Bhaskar, Luke Miller, Zebin Wang, Will Wheaton, Navdeep Chandel, Markku Laakso, William J Muller, Eric L Allen,[...]. Cancer Cell 2013
505
5

Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth.
Lei Wang, Hua Xiong, Fengxia Wu, Yingjie Zhang, Ji Wang, Liyan Zhao, Xiaolan Guo, Li-Ju Chang, Yong Zhang, M James You,[...]. Cell Rep 2014
172
5

ROS stress in cancer cells and therapeutic implications.
Helene Pelicano, Dennis Carney, Peng Huang. Drug Resist Updat 2004
5

Otto Warburg's contributions to current concepts of cancer metabolism.
Willem H Koppenol, Patricia L Bounds, Chi V Dang. Nat Rev Cancer 2011
5

Mitochondrial metabolism and cancer.
Paolo Ettore Porporato, Nicoletta Filigheddu, José Manuel Bravo-San Pedro, Guido Kroemer, Lorenzo Galluzzi. Cell Res 2018
471
5

The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V Liberti, Jason W Locasale. Trends Biochem Sci 2016
5


PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis.
Valerie S LeBleu, Joyce T O'Connell, Karina N Gonzalez Herrera, Harriet Wikman, Klaus Pantel, Marcia C Haigis, Fernanda Machado de Carvalho, Aline Damascena, Ludmilla Thome Domingos Chinen, Rafael M Rocha,[...]. Nat Cell Biol 2014
772
5


A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.
Sébastien Bonnet, Stephen L Archer, Joan Allalunis-Turner, Alois Haromy, Christian Beaulieu, Richard Thompson, Christopher T Lee, Gary D Lopaschuk, Lakshmi Puttagunta, Sandra Bonnet,[...]. Cancer Cell 2007
4

Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death.
Gang Cheng, Jacek Zielonka, Brian P Dranka, Donna McAllister, A Craig Mackinnon, Joy Joseph, Balaraman Kalyanaraman. Cancer Res 2012
172
4

Glycolysis inhibition for anticancer treatment.
H Pelicano, D S Martin, R-H Xu, P Huang. Oncogene 2006
997
4

Mitochondria-targeted small molecule therapeutics and probes.
Robin A J Smith, Richard C Hartley, Michael P Murphy. Antioxid Redox Signal 2011
255
4

Targeting antioxidants to mitochondria by conjugation to lipophilic cations.
Michael P Murphy, Robin A J Smith. Annu Rev Pharmacol Toxicol 2007
783
4

Alpha-tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II.
L-F Dong, P Low, J C Dyason, X-F Wang, L Prochazka, P K Witting, R Freeman, E Swettenham, K Valis, J Liu,[...]. Oncogene 2008
213
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.